NCT05129215View on ClinicalTrials.gov

Development and Validation of The Post-RT LARS Prediction Model (PORTLARS)

CompletedOBSERVATIONAL
Enrollment

901

Participants

Timeline

Start Date

March 6, 2020

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Low Anterior Resection SyndromeRadiotherapyRectal Cancer
Interventions
OTHER

Questionnaire

The LARS score is used for assessment of bowel dysfunction after rectal cancer resection.

Trial Locations (1)

510000

Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
collaborator

Peking University Cancer Hospital & Institute

OTHER

collaborator

Beijing Friendship Hospital

OTHER

lead

Sixth Affiliated Hospital, Sun Yat-sen University

OTHER

NCT05129215 - Development and Validation of The Post-RT LARS Prediction Model (PORTLARS) | Biotech Hunter | Biotech Hunter